The development, testing and evaluation of a COVID-19 fundamental nursing care protocol
Not Applicable
Completed
- Conditions
- COVID-19 (SARS-CoV-2 infection)Infections and Infestations
- Registration Number
- ISRCTN13177364
- Lead Sponsor
- niversity of Exeter
- Brief Summary
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34039574/ (added 28/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34724949/ (added 14/02/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 999
Inclusion Criteria
1. Patients who are not invasively ventilated
2. Aged =18 years
3. Currently hospitalised and treated for infection with the SARS-CoV-2 virus
4. Received nursing care for a minimum of 72 hours during their current admission
Exclusion Criteria
1. Patients who are invasively ventilated
2. Participants unable to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient experience measured using the Quality from the Patient’s Perspective, and the Relational Aspects of Care Questionnaires at a minimum of 72 hours after exposure to the nursing care protocol
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effectiveness of the fundamental nursing care protocol in ISRCTN13177364 for hospitalized non-ventilated COVID-19 patients?
How does the nursing care protocol in ISRCTN13177364 compare to standard-of-care in improving patient outcomes for SARS-CoV-2 infected individuals?
Are there specific biomarkers identified in the ISRCTN13177364 trial that correlate with better clinical responses in non-ventilated hospitalized COVID-19 patients?
What are the potential adverse events associated with the fundamental nursing care protocol in ISRCTN13177364 and how were they managed?
What combination approaches or alternative therapies have been explored alongside nursing care protocols for managing hospitalized non-ventilated SARS-CoV-2 patients in related trials?